PEAR NASDAQ
Boston, MA 02109
US
Pear Therapeutics, Inc. is a commercial-phase medical company focused on inventing and distributing digital therapeutics. Its current offerings include reSET, which addresses substance use disorders involving alcohol, cannabis, cocaine, and stimulants; reSET-O, prescribed alongside buprenorphine for opioid use disorder; and Somryst, a digital solution for chronic insomnia. Beyond these marketed therapies, the company maintains a robust development pipeline of 14 prospective products. These investigational treatments span various therapeutic areas, encompassing psychiatry, neurology, and non-central nervous system conditions like gastrointestinal, oncological, and cardiovascular disorders. Founded in 2013, Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| 5AM Partners IV, LLC | S-Sale | 3,172,769 | $0.12 | 2023-04-10 |
| 5AM Partners IV, LLC | S-Sale | 534,855 | $0.12 | 2023-04-10 |
| Snow Ellen | A-Award | 40,000 | — | 2023-02-16 |
| Snow Ellen | A-Award | 199,864 | — | 2023-02-15 |
| Brenner Erin K. | A-Award | 952,380 | — | 2023-02-15 |